Literature DB >> 3487554

Production of bone-resorbing activity and colony-stimulating activity in vivo and in vitro by a human squamous cell carcinoma associated with hypercalcemia and leukocytosis.

K Sato, H Mimura, D C Han, T Kakiuchi, Y Ueyama, H Ohkawa, T Okabe, Y Kondo, N Ohsawa, T Tsushima.   

Abstract

A squamous cell carcinoma of 33-yr-old patient who developed marked leukocytosis and hypercalcemia was transplanted into nude mice in which more marked leukocytosis and hypercalcemia also developed. This tumor (LJC-1-JCK) produced a colony-stimulating factor (CSF) and formed a cyst in the tumor from which a CSF-producing cell line (T3M-1) was established. The CSF causes predominantly formation of granulocytic colonies in addition to macrophage colonies. Bone-resorbing activity (BRA) was detected in the cystic fluid and was eluted as two separate peaks with proteins of an apparent molecular weight of 30,000-50,000 and 10,000-20,000. Colony-stimulating activity (CSA) was eluted at an apparent 30,000 mol wt. The conditioned medium of the T3M-1 cells also contained a BRA with an apparent 14,000 mol wt, whereas CSA eluted at an apparent 30,000 mol wt. PTH, epidermal growth factor, transforming growth factor-alpha, prostaglandin Es, and vitamin D could not account for the powerful BRA. In contrast to CSA, BRA was not inactivated by trypsin and more stable at 70 degrees C. When T3M-1 cells were transplanted into nude mice, marked hypercalcemia developed in addition to granulocytosis. Our findings suggest that the tumor produces and secretes a powerful BRA in vivo and in vitro, which is different from CSA in terms of molecular weight, heat stability, and trypsin treatment. We speculate that the synergistic action of CSF that stimulates macrophage colony formation and recruits osteoclast precursors, and BRA, which stimulates mononuclear phagocytes and/or osteoclasts were responsible for a marked increase in osteoclastic bone resorption and humoral hypercalcemia in the patient.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3487554      PMCID: PMC329543          DOI: 10.1172/JCI112544

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  Effect of osteoclast activating factor from human leukocytes on bone metabolism.

Authors:  L G Raisz; R A Luben; G R Mundy; J W Dietrich; J E Horton; C L Trummel
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

2.  Isolation of a cationic polypeptide from human serum that stimulates proliferation of 3T3 cells.

Authors:  H N Antoniades; D Stathakos; C D Scher
Journal:  Proc Natl Acad Sci U S A       Date:  1975-07       Impact factor: 11.205

3.  Factors regulating macrophage production and growth. Purification and some properties of the colony stimulating factor from medium conditioned by mouse L cells.

Authors:  E R Stanley; P M Heard
Journal:  J Biol Chem       Date:  1977-06-25       Impact factor: 5.157

4.  Specificities of prostaglandins B 1 , F 1 , and F 2 antigen-antibody reactions.

Authors:  L Levine; R M Gjtierrez Cernosek; H Van Vunakis
Journal:  J Biol Chem       Date:  1971-11-25       Impact factor: 5.157

5.  Granulocytosis associated with tumor cell production of colony-stimulating activity.

Authors:  W Hocking; J Goodman; D Golde
Journal:  Blood       Date:  1983-03       Impact factor: 22.113

Review 6.  The origin of osteoclasts.

Authors:  J F Loutit; N W Nisbet
Journal:  Immunobiology       Date:  1982-04       Impact factor: 3.144

7.  Human renal carcinoma cells produce hypercalcemia in the nude mouse and a novel protein recognized by parathyroid hormone receptors.

Authors:  G J Strewler; R D Williams; R A Nissenson
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

8.  Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy.

Authors:  A F Stewart; K L Insogna; D Goltzman; A E Broadus
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

9.  Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity.

Authors:  A F Stewart; A Vignery; A Silverglate; N D Ravin; V LiVolsi; A E Broadus; R Baron
Journal:  J Clin Endocrinol Metab       Date:  1982-08       Impact factor: 5.958

10.  Association of hypercalcemia with tumors producing colony-stimulating factor(s).

Authors:  Y Kondo; K Sato; H Ohkawa; Y Ueyama; T Okabe; N Sato; S Asano; M Mori; N Ohsawa; K Kosaka
Journal:  Cancer Res       Date:  1983-05       Impact factor: 12.701

View more
  10 in total

Review 1.  Hypercalcemia of malignancy revisited.

Authors:  G R Mundy
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

2.  Esophageal small cell carcinoma with ectopic production of parathyroid hormone-related protein (PTHrp), secretin, and granulocyte colony-stimulating factor (G-CSF).

Authors:  R Nagashima; K Mabe; T Takahashi
Journal:  Dig Dis Sci       Date:  1999-07       Impact factor: 3.199

3.  A case of gallbladder cancer producing granulocyte-colony-stimulating factor.

Authors:  T Takeda; A Ichiyanagi; K Sano; J Yoshida; Y Tsutsumi; T Miyaji
Journal:  Gastroenterol Jpn       Date:  1990-12

4.  Establishment of a human anaplastic thyroid cancer cell line secreting granulocyte colony-stimulating factor in response to cytokines.

Authors:  Y Oka; T Kobayashi; S Fujita; N Matsuura; S Okamoto; H Asakawa; A Murata; T Mori
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-07       Impact factor: 2.416

Review 5.  Hypercalcaemia of malignancy.

Authors:  P J Kelly; J A Eisman
Journal:  Cancer Metastasis Rev       Date:  1989-06       Impact factor: 9.264

6.  Spontaneous production of bone-resorbing lymphokines by B cells in patients with systemic lupus erythematosus.

Authors:  Y Tanaka; K Watanabe; M Suzuki; K Saito; S Oda; H Suzuki; S Eto; U Yamashita
Journal:  J Clin Immunol       Date:  1989-09       Impact factor: 8.317

7.  Bone-resorbing cytokines enhance release of macrophage colony-stimulating activity by the osteoblastic cell MC3T3-E1.

Authors:  R Felix; H Fleisch; P R Elford
Journal:  Calcif Tissue Int       Date:  1989-05       Impact factor: 4.333

8.  Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice.

Authors:  T Yoneda; M A Alsina; J B Chavez; L Bonewald; R Nishimura; G R Mundy
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

Review 9.  Animal Models of Cancer-Associated Hypercalcemia.

Authors:  Nicole A Kohart; Said M Elshafae; Justin T Breitbach; Thomas J Rosol
Journal:  Vet Sci       Date:  2017-04-13

10.  Effects of glucocorticoids and calcitonin on parathyroid hormone-related protein (PTHrP) gene expression and PTHrP release in human cancer cells causing humoral hypercalcemia.

Authors:  K Kasono; O Isozaki; K Sato; Y Sato; K Shizume; K Ohsumi; H Demura
Journal:  Jpn J Cancer Res       Date:  1991-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.